Product Program year 2024 Source: CMS Open Payments

BD Introsyte

Device Vascular/Oncology

PDI 50382903840507

Open in the dashboard

General payments

$5,150

119 payments

Research payments

$0

0 payments

Through program year 2024, $5,150 in general payments and $0 in research payments were reported against BD Introsyte (Vascular/Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2024 General $3,660 83
2023 General $1,490 36

Breakdown

Who paid General payments · program years 2023–2024
  1. Becton, Dickinson and Company $5,150 119 payments
Top recipients General payments · program year 2024
  1. Reema Basu Pediatrics · Orange, CA $45 1% · 1 payment
  2. Sung Park Thoracic Surgery (Cardiothoracic Vascular Surgery) · Hershey, PA $45 1% · 1 payment
  3. Bart Gatz Pain Medicine · Greenacres, FL $45 1% · 1 payment
  4. Stephen Ang Gastroenterology · Centralia, IL $45 1% · 1 payment
  5. Christopher Hogan Emergency Medicine · Richmond, VA $45 1% · 1 payment

The top 5 of 83 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Family Medicine $405 11% · 9 practitioners
  2. Anesthesiology $315 9% · 7 practitioners
  3. Cardiovascular Disease Internal Medicine $270 7% · 6 practitioners
  4. Emergency Medicine $225 6% · 5 practitioners
  5. Internal Medicine $225 6% · 5 practitioners

The top 5 of 37 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. California $585 16% · 13 recipients
  2. Illinois $405 11% · 9 recipients
  3. New York $360 10% · 8 recipients
  4. Florida $345 9% · 8 recipients
  5. Pennsylvania $315 9% · 7 recipients

The top 5 of 27 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

119 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record